| Nicotine and metabolites in paired umbilical cord tissue and meconium specimens. | |
| | |
MedLine Citation:
|
PMID: 21192312 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Umbilical cord tissue was studied as a means of detecting prenatal exposure to nicotine. This was accomplished by comparing the presence and concentration of nicotine as well as nicotine metabolites in both umbilical cord tissue and paired meconium samples with maternal smoking histories obtained by self-report. Nicotine and metabolites (cotinine, 3-hydroxycotinine, nornicotine, and anabasine) were detected and quantitated using liquid chromatography-tandem mass spectroscopy. Between June and September 2009, 19 women with a tobacco exposure history (either first- or second-hand tobacco smoke exposure during pregnancy) were consented for the study. A questionnaire was completed to document nicotine exposure during each trimester of pregnancy. All infants were delivered at term (38 weeks or greater) and paired umbilical cord tissue (10-cm segment or greater) and meconium were obtained. Nicotine and 3-hydroxycotinine were most prominent in meconium, whereas cotinine and 3-hydroxycotinine were most prominent in the umbilical cord. Concentrations of all three analytes were generally higher in meconium. Nornicotine was detected only in meconium, at very low concentrations, and anabasine was not detected in either specimen. All analyte concentrations were lowest when the mother stated she quit smoking early in pregnancy or had only second-hand exposure, and detection was poor if exposure was limited to the first or second trimesters. Although different nicotine and metabolite patterns exist in meconium versus umbilical cord tissue, this work indicates that either specimen can be used to detect third-trimester fetal nicotine exposure. |
| | |
Authors:
|
Stephanie J Marin; Robert D Christensen; Vickie L Baer; Chantry J Clark; Gwendolyn A McMillin |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Therapeutic drug monitoring Volume: 33 ISSN: 1536-3694 ISO Abbreviation: Ther Drug Monit Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-01-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7909660 Medline TA: Ther Drug Monit Country: United States |
Other Details:
|
Languages: eng Pagination: 80-5 Citation Subset: IM |
Affiliation:
|
ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108-1221, USA. stephanie.marin@aruplab.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Adherence to HIV therapeutic drug monitoring guidelines in The Netherlands.
Next Document: Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring.